2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Self Efficacy: new trials by email Literature Review of Self Efficacy trials Research Report on Self Efficacy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach for Hip Surgery QUADRATUS LUMBORUM BLOCK - Self Efficacy | Phase 3 | Unknown | Beni-Suef University | 5 | 2020-11-20 | 2020-11-16 |
| Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C pegylated interferon alpha 2a YPEG-IFN α-2a 180mcg - Self Efficacy, Hepatitis C | Phase 2 / Phase 3 | Unknown | BioGeneric Pharma | 300 | 2010-11-01 | 2011-04-04 |
Hepatitis C (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · RNA Virus Infections (1) · Virus Diseases (1)
Beni-Suef University (1) · BioGeneric Pharma (1)
Egypt (1)
Gamal Esmat, MD (1) · Mohamed Karim F Ashour, MD (1)